Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons

doi:10.4240/wjgs.v11.i7.303

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4967)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

302

WORD

218

HTML

2634

Figures (1-1)

405

Sum=3559

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

575

Download

833

Sum=1408

Jul 27, 2019 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editoral

World J Gastrointest Surg. Jul 27, 2019; 11(7): 303-307
Published online Jul 27, 2019. doi: 10.4240/wjgs.v11.i7.303

Open in New Tab Full Size Figure Download Figure

Figure 1 Images on the left side demonstrate a typical dose distribution for a patient receiving proton therapy for pancreatic cancer. Images on the right side show corresponding dose distributions for the same patient treated with intensity-modulated radiotherapy (IMRT). It is evident that protons are associated with significantly less bowel and gastric exposure compared with the IMRT plan.

Citation: Nichols RC, Rutenberg M. Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons. World J Gastrointest Surg 2019; 11(7): 303-307
URL: https://www.wjgnet.com/1948-9366/full/v11/i7/303.htm
DOI: https://dx.doi.org/10.4240/wjgs.v11.i7.303